Article Sidebar
Views PDF: 100
EVALUATION OF THE RESULTS OF TREATMENT OF DEEP VEIN THROMBOSIS OF THE LOWER LIMBS IN CANCER PATIENTS
Main Article Content
Abstract
Objective: Evaluate the results of treatment of acute deep vein thrombosis (DVT) in cancer patients with rivaroxaban. Research subjects and methods: Cross-sectional study on 45 cancer patients with acute VTE, treated at the Emergency and Intensive Care Department – Vietnam National Cancer Hospital, from March 2020 to September 2020. Results: Common symptoms are edema (95.6%); hot pain (86.7%); Significantly reduced after treatment: edema (15.5%), hot pain (6.7%). Size of lower limb before treatment: thigh (52.3 ± 15.7 cm), caft (28.5 ± 12.8 cm); Reduced after treatment: thigh (41.2 ± 10.4 cm), caft (20.4 ± 10.6 cm). The rate of no recurrence of thrombosis at 1 month follow-up was 82.3%. The bleeding rate during treatment is 11.1% minor bleeding, no major bleeding. D-Dimer levels before and after treatment decreased significantly (6597.4 ± 4503.8 and 1270.3 ± 1490.5). Conclusion: The patient's physical and laboratory symptoms improved significantly after treatment with rivaroxaban, the rate of no recurrence of thrombosis after treatment was high, and side effects were low.
Article Details
References
2. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC).
3. Nguyễn Tiến Đức, Lê Văn Hiệp, 2018. Một vài đặc điểm lâm sàng, cận lâm sàng huyết khối tĩnh mạch sâu trên bệnh nhân ung thư, Đề tài khoa học cấp cơ sở, Bệnh viên K.
4. The EINSTEIN Investigators. N Engl J Med 2010;363:2499–2510.
5. Annie M. Young, Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D), Journal of Clinical Oncology 36, no. 20 (July 10, 2018) 2017-2023.